论文部分内容阅读
目的:探讨阿托伐他汀与曲美他嗪联合用于治疗冠心病的临床疗效。方法:选取2014年5月—2015年5月于我院就诊的冠心病患者共128例,随机分为两组,观察组和对照组各64例患者,对照组患者给予曲美他嗪治疗,观察组患者联合采用曲美他嗪和阿托伐他汀进行治疗,两组患者在接受为期一个月的治疗后,比较两组患者的治疗效果。结果:观察组患者在经过治疗后,总有效率显著高于对照组,P<0.05,差异有统计学意义。结论:阿托伐他汀与曲美他嗪联合用药治疗冠心病临床疗效显著,值得进行临床推广。
Objective: To investigate the clinical efficacy of atorvastatin combined with trimetazidine in the treatment of coronary heart disease. Methods: A total of 128 CHD patients treated in our hospital from May 2014 to May 2015 were randomly divided into two groups: 64 patients in observation group and control group, and the patients in control group were treated with trimetazidine, Patients in the observation group were treated with trimetazidine and atorvastatin, and after two months of treatment, the two groups were compared for the treatment effect. Results: After treatment, the total effective rate in the observation group was significantly higher than that in the control group, P <0.05, the difference was statistically significant. Conclusion: Atorvastatin combined with trimetazidine treatment of coronary heart disease clinical efficacy of significant, worthy of clinical promotion.